| Style | Citing Format |
|---|---|
| MLA | Najdaghi S, et al.. "Autoimmune Hemolytic Anemia After Treatment With Fingolimod in a Patient With Multiple Sclerosis (Ms): A Case Report and Review of the Literature." Autoimmunity Reviews, vol. 21, no. 12, 2022, pp. -. |
| APA | Najdaghi S, Davani DN, Ghajarzadeh M, Shaygannejad V (2022). Autoimmune Hemolytic Anemia After Treatment With Fingolimod in a Patient With Multiple Sclerosis (Ms): A Case Report and Review of the Literature. Autoimmunity Reviews, 21(12), -. |
| Chicago | Najdaghi S, Davani DN, Ghajarzadeh M, Shaygannejad V. "Autoimmune Hemolytic Anemia After Treatment With Fingolimod in a Patient With Multiple Sclerosis (Ms): A Case Report and Review of the Literature." Autoimmunity Reviews 21, no. 12 (2022): -. |
| Harvard | Najdaghi S et al. (2022) 'Autoimmune Hemolytic Anemia After Treatment With Fingolimod in a Patient With Multiple Sclerosis (Ms): A Case Report and Review of the Literature', Autoimmunity Reviews, 21(12), pp. -. |
| Vancouver | Najdaghi S, Davani DN, Ghajarzadeh M, Shaygannejad V. Autoimmune Hemolytic Anemia After Treatment With Fingolimod in a Patient With Multiple Sclerosis (Ms): A Case Report and Review of the Literature. Autoimmunity Reviews. 2022;21(12):-. |
| BibTex | @article{ author = {Najdaghi S and Davani DN and Ghajarzadeh M and Shaygannejad V}, title = {Autoimmune Hemolytic Anemia After Treatment With Fingolimod in a Patient With Multiple Sclerosis (Ms): A Case Report and Review of the Literature}, journal = {Autoimmunity Reviews}, volume = {21}, number = {12}, pages = {-}, year = {2022} } |
| RIS | TY - JOUR AU - Najdaghi S AU - Davani DN AU - Ghajarzadeh M AU - Shaygannejad V TI - Autoimmune Hemolytic Anemia After Treatment With Fingolimod in a Patient With Multiple Sclerosis (Ms): A Case Report and Review of the Literature JO - Autoimmunity Reviews VL - 21 IS - 12 SP - EP - PY - 2022 ER - |